Nalaganje...
Lung cancer therapeutics that target signaling pathways: an update
Claiming more than 150,000 lives each year, lung cancer is the deadliest cancer in the USA. First-line treatments in lung cancer include surgical resection and chemotherapy, the latter of which offers only modest survival benefits at the expense of often severe and debilitating side effects. Recent...
Shranjeno v:
Main Authors: | , , |
---|---|
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
2010
|
Teme: | |
Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3031455/ https://ncbi.nlm.nih.gov/pubmed/20923341 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/ers.10.64 |
Oznake: |
Označite
Brez oznak, prvi označite!
|